High frequency chest wall oscillation	Usual airway clearance techniques	Sputum expectoration between treatments in a 24-hour period	17104	17260	No statistically significant difference was observed in the amount of sputum expectorated when using HFCWO or usual ACT between treatments in a 24 h period.
High frequency chest wall oscillation	Usual airway clearance techniques	Visual analogue scale scores for comfort	18221	18334	No significant differences were observed in VAS scores for comfort or urinary leakage between HFCWO and usual ACT
High frequency chest wall oscillation	Usual airway clearance techniques	Visual analogue scale scores for urinary leakage	18221	18335	No significant differences were observed in VAS scores for comfort or urinary leakage between HFCWO and usual ACT.
High frequency chest wall oscillation	Usual airway clearance techniques	Sputum expectoration over a 24-hour period	-1	-1	Significantly more sputum was expectorated during a single treatment session and over a 24�??h period (mean difference 4.4�??g and 6.9�??g, respectively) with usual ACTs than with HFCWO (p<0.001).
High frequency chest wall oscillation	Usual airway clearance techniques	Sputum expectoration during a single session	-1	-1	Significantly more sputum was expectorated during a single treatment session and over a 24?h period (mean difference 4.4?g and 6.9?g, respectively) with usual ACTs than with HFCWO (p<0.001).
High frequency chest wall oscillation	Usual airway clearance techniques	Adverse events	19947	20036	Neither HFCWO nor any of the usual ACTs were associated with any adverse clinical events.
High frequency chest wall oscillation	Usual airway clearance techniques	Visual analogue scale scores for comfort	18221	18335	No significant differences were observed in VAS scores for comfort or urinary leakage between HFCWO and usual ACT.
High frequency chest wall oscillation	Usual airway clearance techniques	Sputum expectoration during a single session	1189	1379	Significantly more sputum was expectorated during a single treatment session and over a 24 h period (mean difference 4.4 g and 6.9 g, respectively) with usual ACTs than with HFCWO (p<0.001).
High frequency chest wall oscillation	Usual airway clearance techniques	Visual analogue scale scores for efficacy	18336	18453	Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002).
High frequency chest wall oscillation	Usual airway clearance techniques	Sputum expectoration over a 24-hour period	1189	1379	Significantly more sputum was expectorated during a single treatment session and over a 24 h period (mean difference 4.4 g and 6.9 g, respectively) with usual ACTs than with HFCWO (p<0.001).
High frequency chest wall oscillation	Usual airway clearance techniques	Adverse events	19947	20035	Neither HFCWO nor any of the usual ACTs were associated with any adverse clinical events
High frequency chest wall oscillation	Usual airway clearance techniques	O2 saturation	1380	1514	No statistically significant change in FEV1% or oxygen saturation was observed after either HFCWO or usual ACTs compared with baseline
High frequency chest wall oscillation	Usual airway clearance techniques	Visual analogue scale scores for efficacy	18105	18453	The VAS scores for comfort, efficacy and urinary leakage during usual ACT compared with HFCWO are shown in table 4. No significant differences were observed in VAS scores for comfort or urinary leakage between HFCWO and usual ACT. Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002).
High frequency chest wall oscillation	Usual airway clearance techniques	FEV1%	1380	1515	No statistically significant change in FEV1% or oxygen saturation was observed after either HFCWO or usual ACTs compared with baseline.
High frequency chest wall oscillation	Usual airway clearance techniques	O2 saturation	1380	1515	No statistically significant change in FEV1% or oxygen saturation was observed after either HFCWO or usual ACTs compared with baseline.
